Pacer Advisors
RYTM icon

Pacer Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

Pacer Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60K Buy
+538
New +$48.6K ﹤0.01% 1994
2024
Q3 		– Sell
-413
Closed -$17K – 2678
2024
Q2 		$17K Sell
413
-605
-59% -$24.1K ﹤0.01% 3459
2024
Q1 		$44.1K Buy
+1,018
New +$44.6K ﹤0.01% 3218
2021
Q2 		– Sell
-2,845
Closed -$61K – 1538
2021
Q1 		$61K Buy
2,845
+1,462
+106% +$42.4K ﹤0.01% 1415
2020
Q4 		$41K Buy
1,383
+432
+45% +$11K ﹤0.01% 1435
2020
Q3 		$21K Buy
+951
New +$21.8K ﹤0.01% 1354
2018
Q4 		– Sell
-1,608
Closed -$47K – 945
2018
Q3 		$47K Buy
+1,608
New +$50.8K ﹤0.01% 1143

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pacer Advisors's RYTM Position: Q2 2026 in Review

Pacer Advisors opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 538 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #1994 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in RYTM as recently as Q2 2024.

Pacer Advisors first reported a position in RYTM in Q3 2018 and has held it in 7 quarters since. The position peaked at $61K in Q1 2021. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Pacer Advisors held 538 shares of Rhythm Pharmaceuticals worth $60K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Pacer Advisors position in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #1994 holding.
  • Pacer Advisors first reported a position in Rhythm Pharmaceuticals in Q3 2018 and has held it in 7 quarters since.
  • Pacer Advisors's Rhythm Pharmaceuticals position peaked at $61K in Q1 2021.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.